Konsume
Interval Day Week Month
Range 30 Day 90 Day 6 Months 1 Yr
Newswire Search Past 90 Days 30 stories 7 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View
Related Topics
Topic # Mentions Topic Reach
survival8-
positive6-
phase6-
ivonescimab4-
Prominent Journalists
Byline Articles Written Avg Reach
International Association for the Study of Lung CancerSep 15 2026Reviewed 6 -
RTTNews Staff Writer 5 -
by PR Newswire 5 -
International Association for the Study of Lung CancerSep 12 2026Reviewed 3 -
TajSabreen Ahamed 2 -
Gayathry Prakash 2 -
Onmanorama Staff 1 -
University of Texas M. D. Anderson Cancer CenterOct 26 2026Reviewed 1 -
Lara McGrath1, 1 -
By Salong Debbarma 1 -
Chinese Medical JournalSep 2 2026Reviewed 1 -
University of Chicago Medical CenterSep 16 2026Reviewed 1 -


Next generation KRAS inhibitor divarasib significantly extends lung cancer survival
University of Texas M. D. Anderson Cancer CenterOct 26 2026Reviewed — news-medical.net


Roche's Divarasib Cuts Death Risk By 44% In KRAS G12C-Mutated Lung Cancer Phase III Trial
RTTNews Staff Writer — rttnews.com


2026 ESMO
by PR Newswire — thailand-business-news.com


ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2
Lara McGrath1, — nature.com


Pope Leo had lung adenocarcinoma: Why there were no symptoms till a routine check
Onmanorama Staff — english.manoramaonline.com


MAIA Completes THIO-101 Part C Enrollment; Phase 3 Enrollment Hits 65%
RTTNews Staff Writer — rttnews.com


Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC
by PR Newswire — thailand-business-news.com


AI tools help predict immunotherapy outcomes in lung cancer patients
University of Chicago Medical CenterSep 16 2026Reviewed — news-medical.net


OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody
by PR Newswire — thailand-business-news.com


MAIA Biotechnology Board Member, CEO Buy Shares Amid Phase 3 NSCLC Studies
Gayathry Prakash — rttnews.com

Execution: 2.52 Seconds. 31.81 mb used.